|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 101 to 200 out of 245 for Fga

0.031s

Categories

Hits by Pathway

Hits by Category

Hits by Strain

Type Details Score
GXD Expression  
Probe: MGI:1370357
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:1830623
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4824834
Age: embryonic day 14.5
Image: euxassay_002210_10
Specimen Label: euxassay_002210_10
Detected: true
Specimen Num: 10
GXD Expression  
Probe: MGI:1370357
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:1830623
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4824834
Age: embryonic day 14.5
Image: euxassay_002210_11
Specimen Label: euxassay_002210_11
Detected: true
Specimen Num: 11
GXD Expression  
Probe: MGI:1370357
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:1830623
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4824834
Age: embryonic day 14.5
Image: euxassay_002210_12
Specimen Label: euxassay_002210_12
Detected: true
Specimen Num: 12
GXD Expression  
Probe: MGI:1370357
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:1830623
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4824834
Age: embryonic day 14.5
Image: euxassay_002210_13
Specimen Label: euxassay_002210_13
Detected: true
Specimen Num: 13
GXD Expression  
Probe: MGI:1370357
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:1830623
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4824834
Age: embryonic day 14.5
Image: euxassay_002210_14
Specimen Label: euxassay_002210_14
Detected: true
Specimen Num: 14
GXD Expression  
Probe: MGI:1370357
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:1830623
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4824834
Age: embryonic day 14.5
Image: euxassay_002210_15
Specimen Label: euxassay_002210_15
Detected: true
Specimen Num: 15
GXD Expression  
Probe: MGI:1370357
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:1830623
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4824834
Age: embryonic day 14.5
Image: euxassay_002210_16
Specimen Label: euxassay_002210_16
Detected: true
Specimen Num: 16
GXD Expression  
Probe: MGI:1370357
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:1830623
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4824834
Age: embryonic day 14.5
Image: euxassay_002210_17
Specimen Label: euxassay_002210_17
Detected: true
Specimen Num: 17
GXD Expression  
Probe: MGI:1370357
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:1830623
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4824834
Age: embryonic day 14.5
Image: euxassay_002210_18
Specimen Label: euxassay_002210_18
Detected: true
Specimen Num: 18
GXD Expression  
Probe: MGI:1370357
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:1830623
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4824834
Age: embryonic day 14.5
Image: euxassay_002210_19
Specimen Label: euxassay_002210_19
Detected: true
Specimen Num: 19
GXD Expression  
Probe: MGI:1370357
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:1830623
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4824834
Age: embryonic day 14.5
Image: euxassay_002210_20
Specimen Label: euxassay_002210_20
Detected: true
Specimen Num: 20
GXD Expression  
Probe: MGI:1370357
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:1830623
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4824834
Age: embryonic day 14.5
Image: euxassay_002210_21
Specimen Label: euxassay_002210_21
Detected: true
Specimen Num: 21
GXD Expression  
Probe: MGI:1370357
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:1830623
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4824834
Age: embryonic day 14.5
Image: euxassay_002210_22
Specimen Label: euxassay_002210_22
Detected: true
Specimen Num: 22
GXD Expression  
Probe: MGI:1370357
Assay Type: RNA in situ
Annotation Date: 2010-09-14
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:1830623
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4824834
Age: embryonic day 14.5
Image: euxassay_002210_23
Specimen Label: euxassay_002210_23
Detected: true
Specimen Num: 23
GXD Expression  
Probe: MGI:4839927
Assay Type: Immunohistochemistry
Annotation Date: 2010-12-01
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1620420
Pattern: Not Specified
Stage: TS20
Assay Id: MGI:4839928
Age: embryonic day 12.5
Note: There is fibrin deposition in this mutant.
Specimen Label: Not shown
Detected: true
Specimen Num: 12
GXD Expression  
Probe: MGI:6449861
Assay Type: Immunohistochemistry
Annotation Date: 2020-08-14
Strength: Trace
Sex: Not Specified
Emaps: EMAPS:2823927
Pattern: Not Specified
Stage: TS27
Assay Id: MGI:6449990
Age: postnatal newborn
Note: Some traces of fibrin deposition were evident in the glomeruli and tubuli.
Specimen Label: not shown
Detected: true
Specimen Num: 11
GXD Expression
Probe: MGI:4839927
Assay Type: Immunohistochemistry
Annotation Date: 2010-12-01
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1668825
Pattern: Not Specified
Stage: TS25
Assay Id: MGI:4839928
Age: embryonic day 17.5
Image: 1i
Note: There is fibrin deposition.
Specimen Label: 1i
Detected: true
Specimen Num: 3
GXD Expression  
Probe: MGI:4839927
Assay Type: Immunohistochemistry
Annotation Date: 2010-12-01
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1668825
Pattern: Not Specified
Stage: TS25
Assay Id: MGI:4839928
Age: embryonic day 17.5
Note: There is fibrin deposition in this mutant.
Specimen Label: Not shown FVII+/+/PC-/-
Detected: true
Specimen Num: 4
GXD Expression  
Probe: MGI:4839927
Assay Type: Immunohistochemistry
Annotation Date: 2010-12-01
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1668825
Pattern: Not Specified
Stage: TS25
Assay Id: MGI:4839928
Age: embryonic day 17.5
Note: There is fibrin deposition in this mutant.
Specimen Label: Not shown FVII+/-/PC-/-
Detected: true
Specimen Num: 5
GXD Expression    
Probe: MGI:4839927
Assay Type: Immunohistochemistry
Annotation Date: 2010-12-01
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1668825
Stage: TS25
Assay Id: MGI:4839928
Age: embryonic day 17.5
Note: There are no fibrin deposits in wild type embryos.
Specimen Label: Not shown wild type
Detected: false
Specimen Num: 6
GXD Expression    
Probe: MGI:4839927
Assay Type: Immunohistochemistry
Annotation Date: 2010-12-01
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1668825
Stage: TS25
Assay Id: MGI:4839928
Age: embryonic day 17.5
Note: There are no fibrin deposits in this mutant embryo.
Specimen Label: Not shown FVII-/-/PC-+/+
Detected: false
Specimen Num: 7
GXD Expression  
Probe: MGI:4839927
Assay Type: Immunohistochemistry
Annotation Date: 2010-12-01
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1757720
Pattern: Not Specified
Stage: TS20
Assay Id: MGI:4839928
Age: embryonic day 12.5
Note: Fibrin deposits are in the neural canal.
Specimen Label: Not shown
Detected: true
Specimen Num: 12
GXD Expression  
Probe: MGI:4839927
Assay Type: Immunohistochemistry
Annotation Date: 2010-12-01
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1689420
Pattern: Not Specified
Stage: TS20
Assay Id: MGI:4839928
Age: embryonic day 12.5
Image: 3a
Specimen Label: 3a
Detected: true
Specimen Num: 10
GXD Expression  
Probe: MGI:4839927
Assay Type: Immunohistochemistry
Annotation Date: 2010-12-01
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1689425
Pattern: Not Specified
Stage: TS25
Assay Id: MGI:4839928
Age: embryonic day 17.5
Note: There is fibrin deposition in this mutant.
Specimen Label: Not shown FVII+/+/PC-/-
Detected: true
Specimen Num: 4
GXD Expression  
Probe: MGI:4839927
Assay Type: Immunohistochemistry
Annotation Date: 2010-12-01
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1689425
Pattern: Not Specified
Stage: TS25
Assay Id: MGI:4839928
Age: embryonic day 17.5
Note: There is fibrin deposition in this mutant.
Specimen Label: Not shown FVII+/-/PC-/-
Detected: true
Specimen Num: 5
GXD Expression    
Probe: MGI:4839927
Assay Type: Immunohistochemistry
Annotation Date: 2010-12-01
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1689425
Stage: TS25
Assay Id: MGI:4839928
Age: embryonic day 17.5
Note: There are no fibrin deposits in wild type embryos.
Specimen Label: Not shown wild type
Detected: false
Specimen Num: 6
GXD Expression    
Probe: MGI:4839927
Assay Type: Immunohistochemistry
Annotation Date: 2010-12-01
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1689425
Stage: TS25
Assay Id: MGI:4839928
Age: embryonic day 17.5
Note: There are no fibrin deposits in this mutant embryo.
Specimen Label: Not shown FVII-/-/PC-+/+
Detected: false
Specimen Num: 7
GXD Expression  
Probe: MGI:4839927
Assay Type: Immunohistochemistry
Annotation Date: 2010-12-01
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1689422
Pattern: Not Specified
Stage: TS22
Assay Id: MGI:4839928
Age: embryonic day 14.5
Note: Fibron deposition in the brain is less than in the liver.
Specimen Label: Not shown FVII+/-/PC-/-
Detected: true
Specimen Num: 9
GXD Expression  
Probe: MGI:6449861
Assay Type: Immunohistochemistry
Annotation Date: 2020-08-14
Strength: Trace
Sex: Not Specified
Emaps: EMAPS:2778227
Pattern: Not Specified
Stage: TS27
Assay Id: MGI:6449990
Age: postnatal newborn
Note: Some traces of fibrin deposition were evident in the glomeruli and tubuli.
Specimen Label: not shown
Detected: true
Specimen Num: 11
Publication
First Author: Drew AF
Year: 2000
Journal: Circ Res
Title: Plasminogen is a critical determinant of vascular remodeling in mice.
Volume: 87
Issue: 2
Pages: 133-9
Publication
First Author: Raghu H
Year: 2014
Journal: Arthritis Rheumatol
Title: Plasminogen is a joint-specific positive or negative determinant of arthritis pathogenesis in mice.
Volume: 66
Issue: 6
Pages: 1504-16
Publication
First Author: Cortes-Canteli M
Year: 2010
Journal: Neuron
Title: Fibrinogen and beta-amyloid association alters thrombosis and fibrinolysis: a possible contributing factor to Alzheimer's disease.
Volume: 66
Issue: 5
Pages: 695-709
Publication
First Author: Roszell NJ
Year: 2007
Journal: Am J Hematol
Title: Fibrinogen deficiency, but not plasminogen deficiency, increases mortality synergistically in combination with sickle hemoglobin SAD in transgenic mice.
Volume: 82
Issue: 12
Pages: 1044-8
Publication
First Author: Pohl JF
Year: 2001
Journal: Am J Pathol
Title: Plasminogen deficiency leads to impaired lobular reorganization and matrix accumulation after chronic liver injury.
Volume: 159
Issue: 6
Pages: 2179-86
Publication
First Author: Paul J
Year: 2007
Journal: J Exp Med
Title: Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease.
Volume: 204
Issue: 8
Pages: 1999-2008
Publication
First Author: Bugge TH
Year: 1996
Journal: Cell
Title: Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency.
Volume: 87
Issue: 4
Pages: 709-19
Publication
First Author: Tsirka SE
Year: 1997
Journal: Proc Natl Acad Sci U S A
Title: Neuronal death in the central nervous system demonstrates a non-fibrin substrate for plasmin.
Volume: 94
Issue: 18
Pages: 9779-81
Publication
First Author: Tucker HM
Year: 2004
Journal: Neurosci Lett
Title: Plasmin deficiency does not alter endogenous murine amyloid beta levels in mice.
Volume: 368
Issue: 3
Pages: 285-9
Publication
First Author: Shaw MA
Year: 2017
Journal: J Neurosci
Title: Plasminogen Deficiency Delays the Onset and Protects from Demyelination and Paralysis in Autoimmune Neuroinflammatory Disease.
Volume: 37
Issue: 14
Pages: 3776-3788
Publication
First Author: Drew AF
Year: 1998
Journal: Blood
Title: Ligneous conjunctivitis in plasminogen-deficient mice.
Volume: 91
Issue: 5
Pages: 1616-24
Publication
First Author: Yuasa M
Year: 2015
Journal: J Clin Invest
Title: Fibrinolysis is essential for fracture repair and prevention of heterotopic ossification.
Volume: 125
Issue: 8
Pages: 3117-31
Publication
First Author: Kerlin B
Year: 2004
Journal: Blood
Title: Cause-effect relation between hyperfibrinogenemia and vascular disease.
Volume: 103
Issue: 5
Pages: 1728-34
Publication
First Author: Camerer E
Year: 2004
Journal: Blood
Title: Combined deficiency of protease-activated receptor-4 and fibrinogen recapitulates the hemostatic defect but not the embryonic lethality of prothrombin deficiency.
Volume: 103
Issue: 1
Pages: 152-4
Publication      
First Author: Ryu JK
Year: 2021
Journal: bioRxiv
Title: SARS-CoV-2 spike protein induces abnormal inflammatory blood clots neutralized by fibrin immunotherepy.
Publication
First Author: Luo D
Year: 2012
Journal: Infect Immun
Title: Factor XI-deficient mice display reduced inflammation, coagulopathy, and bacterial growth during listeriosis.
Volume: 80
Issue: 1
Pages: 91-9
Publication
First Author: Jirousková M
Year: 2004
Journal: Blood
Title: Antibody blockade or mutation of the fibrinogen gamma-chain C-terminus is more effective in inhibiting murine arterial thrombus formation than complete absence of fibrinogen.
Volume: 103
Issue: 6
Pages: 1995-2002
Publication
First Author: Raghu H
Year: 2015
Journal: Blood
Title: Transglutaminase factor XIII promotes arthritis through mechanisms linked to inflammation and bone erosion.
Volume: 125
Issue: 3
Pages: 427-37
Publication
First Author: Ni H
Year: 2000
Journal: J Clin Invest
Title: Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen.
Volume: 106
Issue: 3
Pages: 385-92
Publication
First Author: Hattori N
Year: 2000
Journal: J Clin Invest
Title: Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice.
Volume: 106
Issue: 11
Pages: 1341-50
Publication
First Author: Xiao Q
Year: 1998
Journal: J Clin Invest
Title: Fibrinogen deficiency is compatible with the development of atherosclerosis in mice.
Volume: 101
Issue: 5
Pages: 1184-94
Publication
First Author: Palumbo JS
Year: 2005
Journal: Blood
Title: Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells.
Volume: 105
Issue: 1
Pages: 178-85
Publication
First Author: Luyendyk JP
Year: 2011
Journal: Am J Pathol
Title: Fibrinogen deficiency increases liver injury and early growth response-1 (Egr-1) expression in a model of chronic xenobiotic-induced cholestasis.
Volume: 178
Issue: 3
Pages: 1117-25
Publication
First Author: Ahn HJ
Year: 2014
Journal: J Exp Med
Title: A novel Aβ-fibrinogen interaction inhibitor rescues altered thrombosis and cognitive decline in Alzheimer's disease mice.
Volume: 211
Issue: 6
Pages: 1049-62
Publication
First Author: Palumbo JS
Year: 2004
Journal: J Thromb Haemost
Title: Role of fibrinogen- and platelet-mediated hemostasis in mouse embryogenesis and reproduction.
Volume: 2
Issue: 8
Pages: 1368-79
Publication
First Author: Samara GJ
Year: 2004
Journal: Laryngoscope
Title: The effects of the plasminogen pathway on scar tissue formation.
Volume: 114
Issue: 1
Pages: 46-9
Publication
First Author: Shanmukhappa K
Year: 2005
Journal: Proc Natl Acad Sci U S A
Title: Hepatic to pancreatic switch defines a role for hemostatic factors in cellular plasticity in mice.
Volume: 102
Issue: 29
Pages: 10182-7
Publication
First Author: Cole HA
Year: 2014
Journal: Arthritis Rheumatol
Title: Fibrin accumulation secondary to loss of plasmin-mediated fibrinolysis drives inflammatory osteoporosis in mice.
Volume: 66
Issue: 8
Pages: 2222-33
Publication
First Author: Miszta A
Year: 2020
Journal: Blood
Title: A high-fat diet delays plasmin generation in a thrombomodulin-dependent manner in mice.
Volume: 135
Issue: 19
Pages: 1704-1717
Publication
First Author: Sun H
Year: 2009
Journal: Blood
Title: Reduced thrombin generation increases host susceptibility to group A streptococcal infection.
Volume: 113
Issue: 6
Pages: 1358-64
Publication  
First Author: Davalos D
Year: 2012
Journal: Nat Commun
Title: Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation.
Volume: 3
Pages: 1227
Publication
First Author: Montagne A
Year: 2018
Journal: Nat Med
Title: Pericyte degeneration causes white matter dysfunction in the mouse central nervous system.
Volume: 24
Issue: 3
Pages: 326-337
Publication
First Author: Dunne E
Year: 2012
Journal: Arterioscler Thromb Vasc Biol
Title: Cadherin 6 has a functional role in platelet aggregation and thrombus formation.
Volume: 32
Issue: 7
Pages: 1724-31
Publication
First Author: Negrón O
Year: 2022
Journal: PLoS Pathog
Title: Fibrin(ogen) engagement of S. aureus promotes the host antimicrobial response and suppression of microbe dissemination following peritoneal infection.
Volume: 18
Issue: 1
Pages: e1010227
Publication
First Author: Sakao E
Year: 2003
Journal: J Biol Chem
Title: Two-peaked synchronization in day/night expression rhythms of the fibrinogen gene cluster in the mouse liver.
Volume: 278
Issue: 33
Pages: 30450-7
Publication
First Author: Ishiguro K
Year: 2000
Journal: J Clin Invest
Title: Complete antithrombin deficiency in mice results in embryonic lethality.
Volume: 106
Issue: 7
Pages: 873-8
Publication
First Author: Vidal B
Year: 2008
Journal: Genes Dev
Title: Fibrinogen drives dystrophic muscle fibrosis via a TGFbeta/alternative macrophage activation pathway.
Volume: 22
Issue: 13
Pages: 1747-52
Publication
First Author: Mullarky IK
Year: 2007
Journal: Infect Immun
Title: Gamma interferon suppresses erythropoiesis via interleukin-15.
Volume: 75
Issue: 5
Pages: 2630-3
Publication
First Author: Camerer E
Year: 2004
Journal: Blood
Title: Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis.
Volume: 104
Issue: 2
Pages: 397-401
Publication
First Author: Sullivan BP
Year: 2012
Journal: Am J Pathol
Title: Fibrin(ogen)-independent role of plasminogen activators in acetaminophen-induced liver injury.
Volume: 180
Issue: 6
Pages: 2321-9
Publication
First Author: Silva LM
Year: 2019
Journal: Blood
Title: Plasmin-mediated fibrinolysis enables macrophage migration in a murine model of inflammation.
Volume: 134
Issue: 3
Pages: 291-303
Publication
First Author: Camerer E
Year: 2006
Journal: Blood
Title: Roles of protease-activated receptors in a mouse model of endotoxemia.
Volume: 107
Issue: 10
Pages: 3912-21
Publication
First Author: Mendiola AS
Year: 2023
Journal: Nat Immunol
Title: Defining blood-induced microglia functions in neurodegeneration through multiomic profiling.
Volume: 24
Issue: 7
Pages: 1173-1187
Publication
First Author: Yin ZF
Year: 2000
Journal: Proc Natl Acad Sci U S A
Title: Prothrombotic phenotype of protein Z deficiency.
Volume: 97
Issue: 12
Pages: 6734-8
Publication
First Author: Merlini M
Year: 2019
Journal: Neuron
Title: Fibrinogen Induces Microglia-Mediated Spine Elimination and Cognitive Impairment in an Alzheimer's Disease Model.
Volume: 101
Issue: 6
Pages: 1099-1108.e6
Publication
First Author: Palumbo JS
Year: 2007
Journal: Blood
Title: Tumor cell-associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell-dependent and-independent mechanisms.
Volume: 110
Issue: 1
Pages: 133-41
Publication
First Author: Vidal B
Year: 2012
Journal: Hum Mol Genet
Title: Amelioration of Duchenne muscular dystrophy in mdx mice by elimination of matrix-associated fibrin-driven inflammation coupled to the αMβ2 leukocyte integrin receptor.
Volume: 21
Issue: 9
Pages: 1989-2004
Publication
First Author: Flick MJ
Year: 2007
Journal: J Clin Invest
Title: Fibrin(ogen) exacerbates inflammatory joint disease through a mechanism linked to the integrin alphaMbeta2 binding motif.
Volume: 117
Issue: 11
Pages: 3224-35
Publication
First Author: Isermann B
Year: 2003
Journal: Nat Med
Title: The thrombomodulin-protein C system is essential for the maintenance of pregnancy.
Volume: 9
Issue: 3
Pages: 331-7
Publication
First Author: Adams GN
Year: 2015
Journal: Cancer Res
Title: Colon Cancer Growth and Dissemination Relies upon Thrombin, Stromal PAR-1, and Fibrinogen.
Volume: 75
Issue: 19
Pages: 4235-43
Publication
First Author: Jalbert LR
Year: 1998
Journal: J Clin Invest
Title: Inactivation of the gene for anticoagulant protein C causes lethal perinatal consumptive coagulopathy in mice.
Volume: 102
Issue: 8
Pages: 1481-8
Publication  
First Author: Broze GJ Jr
Year: 1998
Journal: Blood Coagul Fibrinolysis
Title: Tissue factor pathway inhibitor gene disruption.
Volume: 9 Suppl 1
Pages: S89-92
Publication
First Author: Gu JM
Year: 2002
Journal: J Biol Chem
Title: Disruption of the endothelial cell protein C receptor gene in mice causes placental thrombosis and early embryonic lethality.
Volume: 277
Issue: 45
Pages: 43335-43
Publication
First Author: Yang H
Year: 2009
Journal: Blood
Title: Fibrinogen is required for maintenance of platelet intracellular and cell-surface P-selectin expression.
Volume: 114
Issue: 2
Pages: 425-36
Publication
First Author: Luo D
Year: 2013
Journal: J Immunol
Title: Fibrin facilitates both innate and T cell-mediated defense against Yersinia pestis.
Volume: 190
Issue: 8
Pages: 4149-61
Publication
First Author: Munks MW
Year: 2010
Journal: Blood
Title: Aluminum adjuvants elicit fibrin-dependent extracellular traps in vivo.
Volume: 116
Issue: 24
Pages: 5191-9
Publication
First Author: Luo D
Year: 2011
Journal: J Immunol
Title: Protective roles for fibrin, tissue factor, plasminogen activator inhibitor-1, and thrombin activatable fibrinolysis inhibitor, but not factor XI, during defense against the gram-negative bacterium Yersinia enterocolitica.
Volume: 187
Issue: 4
Pages: 1866-76
Publication
First Author: Yang H
Year: 2006
Journal: J Thromb Haemost
Title: Fibrinogen and von Willebrand factor-independent platelet aggregation in vitro and in vivo.
Volume: 4
Issue: 10
Pages: 2230-7
Publication
First Author: Reheman A
Year: 2009
Journal: Blood
Title: Plasma fibronectin depletion enhances platelet aggregation and thrombus formation in mice lacking fibrinogen and von Willebrand factor.
Volume: 113
Issue: 8
Pages: 1809-17
Publication
First Author: Tolhurst G
Year: 2005
Journal: Blood
Title: Interplay between P2Y(1), P2Y(12), and P2X(1) receptors in the activation of megakaryocyte cation influx currents by ADP: evidence that the primary megakaryocyte represents a fully functional model of platelet P2 receptor signaling.
Volume: 106
Issue: 5
Pages: 1644-51
Publication
First Author: Chan JC
Year: 2000
Journal: J Clin Invest
Title: Combined factor VII/protein C deficiency results in intrauterine coagulopathy in mice.
Volume: 105
Issue: 7
Pages: 897-903
Publication
First Author: Iwaki T
Year: 2002
Journal: Am J Pathol
Title: Fibrinogen stabilizes placental-maternal attachment during embryonic development in the mouse.
Volume: 160
Issue: 3
Pages: 1021-34
Publication
First Author: Motley MP
Year: 2016
Journal: Blood
Title: A CCR2 macrophage endocytic pathway mediates extravascular fibrin clearance in vivo.
Volume: 127
Issue: 9
Pages: 1085-96
Publication
First Author: Hernandez GE
Year: 2022
Journal: Nat Cardiovasc Res
Title: Aortic intimal resident macrophages are essential for maintenance of the non-thrombogenic intravascular state.
Volume: 1
Issue: 1
Pages: 67-84
Publication
First Author: Crosswhite PL
Year: 2016
Journal: J Clin Invest
Title: CHD4-regulated plasmin activation impacts lymphovenous hemostasis and hepatic vascular integrity.
Volume: 126
Issue: 6
Pages: 2254-66
Publication
First Author: Zovein AC
Year: 2010
Journal: Dev Cell
Title: Beta1 integrin establishes endothelial cell polarity and arteriolar lumen formation via a Par3-dependent mechanism.
Volume: 18
Issue: 1
Pages: 39-51
Publication
First Author: Chan JC
Year: 2001
Journal: Am J Pathol
Title: The characterization of mice with a targeted combined deficiency of protein c and factor XI.
Volume: 158
Issue: 2
Pages: 469-79
Publication
First Author: Pfister S
Year: 2011
Journal: Int J Dev Biol
Title: Sox17-dependent gene expression and early heart and gut development in Sox17-deficient mouse embryos.
Volume: 55
Issue: 1
Pages: 45-58
Publication
First Author: Ong K
Year: 2000
Journal: Thromb Haemost
Title: Early embryonic expression of murine coagulation system components.
Volume: 84
Issue: 6
Pages: 1023-30
Publication
First Author: Fenske TS
Year: 2006
Journal: Cancer Res
Title: Identification of candidate alkylator-induced cancer susceptibility genes by whole genome scanning in mice.
Volume: 66
Issue: 10
Pages: 5029-38
Publication
First Author: Trinidad JC
Year: 2006
Journal: Mol Cell Proteomics
Title: Comprehensive identification of phosphorylation sites in postsynaptic density preparations.
Volume: 5
Issue: 5
Pages: 914-22